The Endoscope Reprocessing Device Market is poised for substantial growth over the next decade. Estimated at USD 2.68 billion in 2025, the market is projected to reach USD 4.94 billion by 2035, reflecting a robust CAGR of 7.3%. This surge is largely fueled by an increasing number of endoscopic procedures due to rising cardiovascular and gastrointestinal health concerns, coupled with heightened awareness of Healthcare-Associated Infections (HAIs) in hospitals worldwide.
Explore trends before investing – request a sample report today!
Request Sample Report
Regulatory Compliance Driving Device Adoption
Healthcare facilities are rapidly adopting endoscope reprocessing devices to comply with stringent global regulations. Regulatory bodies such as the CDC, FDA, AAMI, and EU MDR mandate high-level disinfection and sterilization of endoscopes to prevent cross-contamination. Non-compliance can result in severe penalties, reputational damage, and patient safety risks. Modern innovations, including automated endoscope reprocessors (AERs), hydrogen peroxide vapor systems, barcode tracking, and eco-friendly disinfectants, are helping facilities meet these stringent standards efficiently.
Market Segmentation Highlights: Hospitals Lead Adoption
Hospitals dominate the endoscope reprocessing device market, capturing 55.6% of the market share in 2025. The preference for automated endoscope reprocessors (45.3% market share) is driven by their efficiency, safety, and compliance with regulatory requirements. These devices reduce processing time, minimize human contact with contaminated instruments, and integrate seamlessly with hospital management systems. Mobile reprocessing devices also provide operational flexibility, enabling healthcare facilities to optimize workflow and manage space constraints effectively.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates –
Subscribe Now
Regional Market Insights: APAC and Europe Lead the Way
The APAC region, particularly India and South Korea, is expected to experience the fastest growth, with CAGRs of 10.4% and 9.5%, respectively, between 2025 and 2035. Government healthcare initiatives, rising medical tourism, and investment in advanced medical facilities are driving adoption.
In Europe, Germany’s market is projected to grow at 4% CAGR, supported by strict EU MDR and Robert Koch Institute guidelines. The United States shows steady growth at 4% CAGR, driven by the aging population, advanced EHR integration, and IoT-enabled devices. Japan’s market, although more conservative with a 2.6% CAGR, benefits from a preference for minimally invasive surgeries and the global reach of Japanese manufacturers like Olympus.
Technological Innovation Shapes Competitive Landscape
Competition in the endoscope reprocessing device market is fierce, with companies focusing on technological advancements to maintain market share. Key players like Getinge, Olympus Corporation, STERIS plc, HOYA Corporation, and Steelco S.p.A. are introducing solutions that enhance automation, connectivity, and compliance. Notable initiatives include HOYA’s acquisition of Wassenburg Medical B.V. and Getinge’s Enhanced ED-Flow AER launch, demonstrating the industry’s focus on digital integration and operational efficiency.
Overcoming Cost Challenges
Despite strong growth, the market faces barriers due to high upfront investment and maintenance costs of sophisticated devices. Training staff, procuring consumables, and upgrading infrastructure adds to operational expenses, particularly for small and medium-sized healthcare facilities. However, the long-term savings in labor costs and improved infection control continue to drive adoption globally.
Buy Report Now – Click Here to Purchase the Report:
Purchase Report
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
